Pfizer launches new antibiotic in the UK
Pfizer’s antibiotic Zavicefta has now been launched in the UK to treat serious aerobic Gram-negative infections caused by resistant bacteria.
Read More
Tag: Zavicefta
US regulators expand use of Allergan’s antibiotic
The US Food and Drug Administration has agreed to expand the label of Dublin, Ireland-based Allergan’s Avycaz to include the treatment of complicated urinary tract infections (cUTI).
Read More
Study data back efficacy of AZ novel antibiotic
A late-stage study has confirmed the efficacy of AstraZeneca’s new combination antibiotic Zavicefta in patients with hospital acquired pneumonia (HAP), including ventilator associated pneumonia (VAP).
Read More
EU clears AstraZeneca’s new antibiotic
AstraZeneca’s Zavicefta has been approved for use in the European Union to treat patients with serious Gram-negative bacterial infections requiring hospitalisation.
Read More
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
